Author: Praveen Suthrum

When we eat food, our gut somehow senses its presence to begin shifting it along our digestive tract, but the question has always been – how? Now, new Flinders University research using both human gut samples and mice has discovered that a touch-sensing protein that was a focus of a 2021 Nobel Prize, called Piezo2, is not just in our fingers, but also in our gut, with its presence likely playing a key role in constipation. This work has recently been published in the leading international journal Gastroenterology.

Read More

Originally published by our sister publication, Gastroenterology & Endoscopy News Klebsiella pneumoniae, which is found in higher concentrations in patients with inflammatory bowel disease, enhances the growth of Clostridioides difficile and worsens colonic inflammation in the presence of C. difficile infection, according to new research. “When C. difficile infection is superimposed on colitis, it synergistically worsens both conditions,” researcher Taylor Ticer, a PhD candidate at the Medical University of South Carolina, in Charleston, and colleagues reported at the 2022 Crohn’s and Colitis Congress (Inflamm Bowel Dis 2022;28[suppl 1]:S69).

Read More

CENTER VALLEY, Pa., March 8, 2022 /PRNewswire/ — Olympus, a global technology leader in endoscopy, offers a reminder about the importance of screening for colorectal cancer, which may be preventable and treatable when found early. March marks Colorectal Cancer Awareness Month, and Olympus encourages people to talk to their doctors about getting screened. The United States Preventive Services Task Force last year lowered the recommended age for colorectal cancer screenings for adults from 50 to 45.1 The Multi-Society Taskforce, which includes the American College of Gastroenterology (ACG), the American Gastroenterological Association (AGA), and the American Society for Gastrointestinal Endoscopy (ASGE), announced its full…

Read More

FROM CROHN’S & COLITIS CONGRESS As the saying goes: “Age is a case of mind over matter: If you don’t mind, it don’t matter.” But for older patients with inflammatory bowel disease (IBD) and the clinicians who treat them, it’s hard to ignore the complications that aging can bring, such as comorbidities, functional limitations, and polypharmacy, said Nana Bernasko, CRNP, DNP, WHNP-BC, a nurse practitioner in the department of gastroenterology at Penn State Milton S. Hershey Medical Center in Hershey, Pa.

Read More

Here are 10 physicians who specialize in gastroenterology to know: Note: This is not an exhaustive list. Physicians are listed in alphabetical order. To nominate a physician for future lists, please contact Riz Hatton at rhatton@beckershealthcare.com. Maisa Abdalla, MD. Loma Linda (Calif.) University Medical Center. Dr. Abdalla has served as an assistant professor of medicine at Loma Linda University Medical Center since 2016. She practices there and at Riverside University Health System in Moreno Valley, Calif. She aims to improve accessibility and quality in patient care.

Read More

An intensive multidisciplinary lifestyle management program that results in significant weight loss reduces steatosis and fibrosis in pediatric patients with nonalcoholic fatty liver disease, according to a new study from Belgium. Secondary to increasing rates of obesity in children and adolescents, pediatric NAFLD is now the most common pediatric liver disease worldwide, according to investigator Sander Lefere, MD, PhD, a postdoctoral researcher in the Department of Gastroenterology and Hepatology at Ghent University, in Belgium.

Read More

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostics Services program (MolDX), has conveyed coverage for Guardant360 TissueNext™ under the existing local coverage determination (LCD) (MolDX: Next-Generation Sequencing for Solid Tumors). Guardant360 TissueNext is the company’s first tissue-based test to help oncologists identify patients with advanced cancer who may benefit from biomarker-informed treatment.

Read More